{{Rsnum
|rsid=6478241
|Gene=ASTN2
|Chromosome=9
|position=116490350
|Orientation=plus
|GMAF=0.4522
|Gene_s=ASTN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.8 | 44.2 | 38.9
| HCB | 16.2 | 44.1 | 39.7
| JPT | 6.2 | 46.0 | 47.8
| YRI | 61.9 | 31.3 | 6.8
| ASW | 29.8 | 59.6 | 10.5
| CHB | 16.2 | 44.1 | 39.7
| CHD | 9.3 | 46.3 | 44.4
| GIH | 14.9 | 34.7 | 50.5
| LWK | 67.3 | 30.0 | 2.7
| MEX | 7.0 | 40.4 | 52.6
| MKK | 53.8 | 38.5 | 7.7
| TSI | 17.0 | 38.0 | 45.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22683712
|Trait=None
|Title=Genome-wide association analysis identifies susceptibility loci for migraine without aura.
|RiskAllele=A
|Pval=4E-8
|OR=1.1600
|ORtxt=None
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23793025
  |Trait=Migraine - clinic-based
  |Title=Genome-wide meta-analysis identifies new susceptibility loci for migraine.
  |RiskAllele=A
  |Pval=1E-9
  |OR=1.16
  |ORtxt=[1.11-1.22]
  }}

{{PMID Auto
|PMID=24674449
|Title=A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample
|OA=1
}}

{{PMID Auto
|PMID=25179292
|Title=Concordance of genetic risk across migraine subgroups: Impact on current and future genetic association studies
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}